Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05168605 · ClinicalTrials.gov registry record · NA

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

A NA study of Hypertension and Type 2 Diabetes, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05168605 is a NA study of Hypertension and Type 2 Diabetes that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05168605, a NA study of Hypertension and Type 2 Diabetes, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

Interventions

  • OTHER Home visit

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-07-27
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT05168605

The ClinicalTrials.gov registry entry for NCT05168605 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Home visit is the first listed.

NCT05168605 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05168605 about?

NCT05168605 is a clinical study titled "Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions". The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

What is the current status of trial NCT05168605?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-07-27. Estimated completion is 2026-12-31.

What conditions does trial NCT05168605 study?

This clinical trial studies the following conditions: Hypertension, Type 2 Diabetes.

What interventions are being tested in trial NCT05168605?

The interventions under investigation include: Home visit (OTHER).

Who is sponsoring clinical trial NCT05168605?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05168605 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.